Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 5
2005 2
2006 2
2007 1
2008 2
2009 6
2010 6
2011 6
2012 23
2013 13
2014 13
2015 8
2016 19
2017 20
2018 16
2019 7
2020 17
2021 13
2022 14
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Where Morphological and Molecular Classifications Meet: The Role of p53 Immunohistochemistry in the Prognosis of Low-Risk Endometrial Carcinoma (GLAMOUR Study).
Puppo A, Fraternali Orcioni G, Clignon V, Musizzano Y, Zavattero CA, Vocino Trucco G, Benazzo GM, Vizzielli G, Restaino S, Mariuzzi L, Orsaria M, Seracchioli R, Raimondo D, Bertoldo L, Uccella S, Caliò A, Vittori Antisari G, Garzon S, Capozzi VA, Berretta R, Cosentino F, Ercoli A, Ieni A, Arcieri M, Ceccaroni M, Pesci A, Mantovani G, Bruni F, Roviglione G, Zeppa P, Raffone A, Camanni M, Delpiano EM, Provenza C, Borghese M, Migliaretti G. Puppo A, et al. Among authors: zeppa p. Cancers (Basel). 2024 Mar 7;16(6):1088. doi: 10.3390/cancers16061088. Cancers (Basel). 2024. PMID: 38539423 Free PMC article.
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.
Polcaro G, Liguori L, Manzo V, Chianese A, Donadio G, Caputo A, Scognamiglio G, Dell'Annunziata F, Langella M, Corbi G, Ottaiano A, Cascella M, Perri F, De Marco M, Col JD, Nassa G, Giurato G, Zeppa P, Filippelli A, Franci G, Piaz FD, Conti V, Pepe S, Sabbatino F. Polcaro G, et al. Among authors: zeppa p. Mol Cancer. 2024 Mar 25;23(1):63. doi: 10.1186/s12943-024-01976-2. Mol Cancer. 2024. PMID: 38528526 Free PMC article.
Malignant tumor diagnoses in cerebrospinal fluid cytology.
Ruotolo R, Zeppa P, Caputo A. Ruotolo R, et al. Among authors: zeppa p. J Am Soc Cytopathol. 2024 Mar-Apr;13(2):156-157. doi: 10.1016/j.jasc.2024.01.001. Epub 2024 Jan 9. J Am Soc Cytopathol. 2024. PMID: 38311506 No abstract available.
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi-institutional study.
Caputo A, Fraggetta F, Cretella P, Cozzolino I, Eccher A, Girolami I, Marletta S, Troncone G, Vigliar E, Acanfora G, Zarra KV, Torres Rivas HE, Fadda G, Field A, Katz R, Vielh P, Eloy C, Rajwanshi A, Gupta N, Al-Abbadi M, Bustami N, Arar T, Calaminici M, Raine JI, Barroca H, Canão PA, Ehinger M, Rajabian N, Dey P, Medeiros LJ, El Hussein S, Lin O, D'Antonio A, Bode-Lesniewska B, Rossi ED, Zeppa P. Caputo A, et al. Among authors: zeppa p. Cancer Cytopathol. 2023 Nov;131(11):679-692. doi: 10.1002/cncy.22741. Epub 2023 Jul 7. Cancer Cytopathol. 2023. PMID: 37418195
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study.
Picardi M, Giordano C, Vigliar E, Zeppa P, Cozzolino I, Pugliese N, Della Pepa R, Esposito M, Abagnale DP, Ciriello M, Muccioli-Casadei G, Troncone G, Russo D, Mascolo M, Varricchio S, Accarino R, Persico M, Pane F. Picardi M, et al. Among authors: zeppa p. Hematol Oncol. 2023 Dec;41(5):817-827. doi: 10.1002/hon.3204. Epub 2023 Jul 6. Hematol Oncol. 2023. PMID: 37415412
177 results